Australian "H1N1 Swine Flu" Clinical Trial Data Show No Adjuvants Tested
Thursday, September 17, 2009
Australian "H1N1 Swine Flu" Clinical Trial Data Show No Adjuvants Tested
Sydney : Australian pharmaceutical company CSL's clinical "swine flu" trial data published on September 10th in the New England Journal of Medicine reveals that vaccines without the dangerous adjuvants were used in the clinical trials - even though Australians are set to be given "swine flu" vaccines with adjuvants.
Also, the trial subjects were healthy adults between the ages of 18 and 64 years old; pregnant women, the elderly and children were, therefore, excluded - even though these are the priority groups for the "swine flu" vaccine.Source
Furthermore, the trials appear to be conducted on the only one of the WHO candidate vaccines that was not engineered by reverse genetics.
http://www.who.int/csr/resources/publications/swineflu/summary_candidate_vaccine.pdf
http://www.who.int/csr/resources/publications/swineflu/ivr153_20090608_en.pdf
Also, the trial subjects were healthy adults between the ages of 18 and 64 years old; pregnant women, the elderly and children were, therefore, excluded - even though these are the priority groups for the "swine flu" vaccine.Source
Furthermore, the trials appear to be conducted on the only one of the WHO candidate vaccines that was not engineered by reverse genetics.
http://www.who.int/csr/resources/publications/swineflu/summary_candidate_vaccine.pdf
http://www.who.int/csr/resources/publications/swineflu/ivr153_20090608_en.pdf
0 comments:
Post a Comment